PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
0.8995
+0.0018 (0.20%)
At close: Nov 17, 2026, 4:00 PM EST
0.9000
+0.0005 (0.06%)
After-hours: Nov 17, 2026, 7:06 PM EST
PetMed Express Market Cap
PetMed Express has a market cap or net worth of $19.08 million as of November 17, 2026. It is the 37,019th most valuable company in the world and the 5,164th biggest in the United States. Its market cap has decreased by 54.58% in one year.
Market Cap
19.08M
Enterprise Value
7.95M
1-Year Change
-54.58%
Global Rank
Country Rank
#5,164 United States
Category
ChartMarket Cap Chart
Since January 23, 2004, PetMed Express's market cap has decreased from $198.30M to $19.08M, a decrease of -90.38%. That is a compound annual growth rate of -9.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 20.00M | -70.76% |
| Dec 31, 2025 | 68.40M | -31.33% |
| Dec 31, 2024 | 99.60M | -37.71% |
| Dec 29, 2023 | 159.90M | -57.13% |
| Dec 30, 2022 | 373.00M | -29.49% |
| Dec 31, 2021 | 529.00M | -18.60% |
| Dec 31, 2020 | 649.90M | 36.97% |
| Dec 31, 2019 | 474.50M | -1.33% |
| Dec 31, 2018 | 480.90M | -48.70% |
| Dec 29, 2017 | 937.50M | 97.99% |
| Dec 30, 2016 | 473.50M | 35.87% |
| Dec 31, 2015 | 348.50M | 19.68% |
| Dec 31, 2014 | 291.20M | -13.28% |
| Dec 31, 2013 | 335.80M | 51.19% |
| Dec 31, 2012 | 222.10M | 5.21% |
| Dec 30, 2011 | 211.10M | -47.98% |
| Dec 31, 2010 | 405.80M | 0.59% |
| Dec 31, 2009 | 403.40M | -2.77% |
| Dec 31, 2008 | 414.90M | 40.07% |
| Dec 31, 2007 | 296.20M | -8.35% |
| Dec 29, 2006 | 323.20M | -3.84% |
| Dec 30, 2005 | 336.10M | 88.61% |
| Dec 31, 2004 | 178.20M | -10.14% |
| Jan 23, 2004 | 198.30M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.29T |
| Johnson & Johnson | 687.89B |
| AbbVie | 521.50B |
| UnitedHealth Group | 365.09B |
| DocGo | 20.55M |
| IGC Pharma | 20.54M |
| Celularity | 20.45M |
| P3 Health Partners | 19.60M |